Development of a Stable Liquid Formulation of Live Attenuated Influenza Vaccine
Existing live attenuated seasonal influenza vaccines may require lyophilization to be stable enough for developing-country use, which adds a significant cost burden and reduces their use and accessibility in low-resource settings. This article, published in Vaccine, reports the results of a study to develop a low-cost, stable liquid formulation for a live attenuated seasonal influenza vaccine. The authors identified a liquid formulation that provided storage stability of one year at 2°C to 8°C for the influenza A and B strains tested.
Author: White JA, Estrada M, Flood EA, Mahmood K, Dhere R, Chen D
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: White JA, Estrada M, Flood EA, Mahmood K, Dhere R, Chen D. Development of a Stable Liquid Formulation of Live Attenuated Influenza Vaccine. Vaccine. 2016;34(32):3676-3683.
Resource types: Peer-reviewed journal